Treatment of early hypertension among persons living with HIV in Haiti: Protocol for a randomized controlled trial.

<h4>Background</h4>People living with HIV (PLWH) are at increased risk of cardiovascular disease (CVD) and death, with greater burdens of both HIV and CVD in lower-middle income countries. Treating prehypertension in PLWH may reduce progression to hypertension, CVD risk and potentially m...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lily D Yan, Vanessa Rouzier, Eliezer Dade, Collette Guiteau, Jean Lookens Pierre, Stephano St-Preux, Miranda Metz, Suzanne Oparil, Jean William Pape, Margaret McNairy
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/eb0a81ba99d6478fb611fb56c3265f46
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:eb0a81ba99d6478fb611fb56c3265f46
record_format dspace
spelling oai:doaj.org-article:eb0a81ba99d6478fb611fb56c3265f462021-12-02T20:15:14ZTreatment of early hypertension among persons living with HIV in Haiti: Protocol for a randomized controlled trial.1932-620310.1371/journal.pone.0254740https://doaj.org/article/eb0a81ba99d6478fb611fb56c3265f462021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0254740https://doaj.org/toc/1932-6203<h4>Background</h4>People living with HIV (PLWH) are at increased risk of cardiovascular disease (CVD) and death, with greater burdens of both HIV and CVD in lower-middle income countries. Treating prehypertension in PLWH may reduce progression to hypertension, CVD risk and potentially mortality. However, no trial has evaluated earlier blood pressure treatment for PLWH. We propose a randomized controlled trial to assess the feasibility, benefits, and risks of initiating antihypertensive treatment among PLWH with prehypertension, comparing prehypertension treatment to standard of care following current WHO guidelines.<h4>Methods</h4>A total of 250 adults 18-65 years and living with HIV (PLWH) with viral suppression in the past 12 months, who have prehypertension will be randomized to prehypertension treatment versus standard of care. Prehypertension is defined as having a systolic blood pressure (SBP) 120-139 mmHg or diastolic blood pressure (DBP) 80-89 mmHg. In the prehypertension treatment arm, participants will initiate amlodipine 5 mg daily immediately. In the standard of care arm, participants will initiate amlodipine only if they develop hypertension defined as SBP ≥ 140 mmHg or DBP ≥ 90 mmHg. The primary outcome is the difference in mean change of SBP from enrollment to 12 months. Secondary outcomes include feasibility, acceptability, adverse effects, HIV viral suppression, and medication adherence. Qualitative in-depth interviews with providers and participants will explore attitudes about initiating amlodipine, satisfaction, perceived CVD risk, and implementation challenges.<h4>Discussion</h4>PLWH have a higher CVD risk and may benefit from a lower BP threshold for initiation of antihypertensive treatment.<h4>Trial registration</h4>Clinicaltrials.gov registration number NCT04692467, registration date December 15, 2020, protocol ID 20-03021735.Lily D YanVanessa RouzierEliezer DadeCollette GuiteauJean Lookens PierreStephano St-PreuxMiranda MetzSuzanne OparilJean William PapeMargaret McNairyPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 8, p e0254740 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Lily D Yan
Vanessa Rouzier
Eliezer Dade
Collette Guiteau
Jean Lookens Pierre
Stephano St-Preux
Miranda Metz
Suzanne Oparil
Jean William Pape
Margaret McNairy
Treatment of early hypertension among persons living with HIV in Haiti: Protocol for a randomized controlled trial.
description <h4>Background</h4>People living with HIV (PLWH) are at increased risk of cardiovascular disease (CVD) and death, with greater burdens of both HIV and CVD in lower-middle income countries. Treating prehypertension in PLWH may reduce progression to hypertension, CVD risk and potentially mortality. However, no trial has evaluated earlier blood pressure treatment for PLWH. We propose a randomized controlled trial to assess the feasibility, benefits, and risks of initiating antihypertensive treatment among PLWH with prehypertension, comparing prehypertension treatment to standard of care following current WHO guidelines.<h4>Methods</h4>A total of 250 adults 18-65 years and living with HIV (PLWH) with viral suppression in the past 12 months, who have prehypertension will be randomized to prehypertension treatment versus standard of care. Prehypertension is defined as having a systolic blood pressure (SBP) 120-139 mmHg or diastolic blood pressure (DBP) 80-89 mmHg. In the prehypertension treatment arm, participants will initiate amlodipine 5 mg daily immediately. In the standard of care arm, participants will initiate amlodipine only if they develop hypertension defined as SBP ≥ 140 mmHg or DBP ≥ 90 mmHg. The primary outcome is the difference in mean change of SBP from enrollment to 12 months. Secondary outcomes include feasibility, acceptability, adverse effects, HIV viral suppression, and medication adherence. Qualitative in-depth interviews with providers and participants will explore attitudes about initiating amlodipine, satisfaction, perceived CVD risk, and implementation challenges.<h4>Discussion</h4>PLWH have a higher CVD risk and may benefit from a lower BP threshold for initiation of antihypertensive treatment.<h4>Trial registration</h4>Clinicaltrials.gov registration number NCT04692467, registration date December 15, 2020, protocol ID 20-03021735.
format article
author Lily D Yan
Vanessa Rouzier
Eliezer Dade
Collette Guiteau
Jean Lookens Pierre
Stephano St-Preux
Miranda Metz
Suzanne Oparil
Jean William Pape
Margaret McNairy
author_facet Lily D Yan
Vanessa Rouzier
Eliezer Dade
Collette Guiteau
Jean Lookens Pierre
Stephano St-Preux
Miranda Metz
Suzanne Oparil
Jean William Pape
Margaret McNairy
author_sort Lily D Yan
title Treatment of early hypertension among persons living with HIV in Haiti: Protocol for a randomized controlled trial.
title_short Treatment of early hypertension among persons living with HIV in Haiti: Protocol for a randomized controlled trial.
title_full Treatment of early hypertension among persons living with HIV in Haiti: Protocol for a randomized controlled trial.
title_fullStr Treatment of early hypertension among persons living with HIV in Haiti: Protocol for a randomized controlled trial.
title_full_unstemmed Treatment of early hypertension among persons living with HIV in Haiti: Protocol for a randomized controlled trial.
title_sort treatment of early hypertension among persons living with hiv in haiti: protocol for a randomized controlled trial.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/eb0a81ba99d6478fb611fb56c3265f46
work_keys_str_mv AT lilydyan treatmentofearlyhypertensionamongpersonslivingwithhivinhaitiprotocolforarandomizedcontrolledtrial
AT vanessarouzier treatmentofearlyhypertensionamongpersonslivingwithhivinhaitiprotocolforarandomizedcontrolledtrial
AT eliezerdade treatmentofearlyhypertensionamongpersonslivingwithhivinhaitiprotocolforarandomizedcontrolledtrial
AT colletteguiteau treatmentofearlyhypertensionamongpersonslivingwithhivinhaitiprotocolforarandomizedcontrolledtrial
AT jeanlookenspierre treatmentofearlyhypertensionamongpersonslivingwithhivinhaitiprotocolforarandomizedcontrolledtrial
AT stephanostpreux treatmentofearlyhypertensionamongpersonslivingwithhivinhaitiprotocolforarandomizedcontrolledtrial
AT mirandametz treatmentofearlyhypertensionamongpersonslivingwithhivinhaitiprotocolforarandomizedcontrolledtrial
AT suzanneoparil treatmentofearlyhypertensionamongpersonslivingwithhivinhaitiprotocolforarandomizedcontrolledtrial
AT jeanwilliampape treatmentofearlyhypertensionamongpersonslivingwithhivinhaitiprotocolforarandomizedcontrolledtrial
AT margaretmcnairy treatmentofearlyhypertensionamongpersonslivingwithhivinhaitiprotocolforarandomizedcontrolledtrial
_version_ 1718374618391117824